Rajabzadeh, A., Mehralian, G., Zarenezhadb, F., Rasekh, H. (2013). Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain. Iranian Journal of Pharmaceutical Research, 12(Supplement), 193-205.
Ali Rajabzadeh; Gholamhossein Mehralian; Forouzandeh Zarenezhadb; Hamid Reza Rasekh. "Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain". Iranian Journal of Pharmaceutical Research, 12, Supplement, 2013, 193-205.
Rajabzadeh, A., Mehralian, G., Zarenezhadb, F., Rasekh, H. (2013). 'Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain', Iranian Journal of Pharmaceutical Research, 12(Supplement), pp. 193-205.
Rajabzadeh, A., Mehralian, G., Zarenezhadb, F., Rasekh, H. Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain. Iranian Journal of Pharmaceutical Research, 2013; 12(Supplement): 193-205.
Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain
2Pharmacoeconomics and Pharma Management Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3Researcher in Institute of Management and Developing of Technology, Affiliated to Tarbiat Modares University, Tehran, Iran.
Abstract
Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutical industry according to the formative basic factors. Moreover, this paper can configure its supply network to achieve the agile supply chain. The present article analyzes the supply part of supply chain based on SCOR model, used to assess agile supply chains by highlighting their specific characteristics and applicability in providing the active pharmaceutical ingredient (API). This methodology provides an analytical modeling; the model enables potential suppliers to be assessed against the multiple criteria using both quantitative and qualitative measures. In addition, for making priority of critical factors, TOPSIS algorithm has been used as a common technique of MADM model. Finally, several factors such as delivery speed, planning and reorder segmentation, trust development and material quantity adjustment are identified and prioritized as critical factors for being agile in supply of API.
Top